Regional differences in baseline demographic and clinical characteristics from the evoke and evoke+ trials of semaglutide for early Alzheimer's disease.

Authors: van der Flier, Wiesje M., Scheltens, Philip, Feldman, Howard H., Hansson, Oskar, Sano, Mary, Bardtrum, Lars, Johannsen, Peter, Jeppesen, Rose, Hansen, Charlotte T., Leon, Teresa, Cummings, Jeffrey L.

Source: Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Dec2024 Supplement 6, Vol. 20 Issue S6, p1-4, 4p

Clinically‐suspected cast nephropathy: A retrospective, national, real‐world study

Authors: Szabo, Agoston G., Thorsen, Jonathan, Iversen, Katrine F., Hansen, Charlotte T., Teodorescu, Elena M., Pedersen, Simon B., Flæng, Simon B., Strandholdt, Casper, Frederiksen, Mikael, Vase, Maja Ø., Frølund, Ulf C., Krustrup, Dorrit, Plesner, Torben, Vangsted, Annette J.

Source: American journal of hematology. 95(11):1352-1360

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100111664115.0x000001&indx=1&recIds=ETOCvdc_100111664115.0x000001

Comparison of eligibility criteria and baseline characteristics between the patient populations of evoke and evoke+, Clarity AD, and TRAILBLAZER‐ALZ‐2.

Authors: Feldman, Howard H., Scheltens, Philip, Hansson, Oskar, Sano, Mary, van der Flier, Wiesje M., Bardtrum, Lars, Johannsen, Peter, Jeppesen, Rose, Leon, Teresa, Hansen, Charlotte T., Cummings, Jeffrey L.

Source: Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Dec2024 Supplement 6, Vol. 20 Issue S6, p1-3, 3p

Lower rates of hypoglycaemia in older individuals with type 2 diabetes using insulin degludec versus insulin glargine U100: Results from SWITCH 2

Authors: Heller, Simon R., DeVries, J. Hans, Wysham, Carol, Hansen, Charlotte T., Hansen, Melissa V., Frier, Brian M.

Source: Diabetes, obesity & metabolism. 21(7):1634-1641

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100083016317.0x000001&indx=1&recIds=ETOCvdc_100083016317.0x000001

Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7)

Authors: Pratley, Richard E., Emerson, Scott S., Franek, Edward, Gilbert, Matthew P., Marso, Steven P., McGuire, Darren K., Pieber, Thomas R., Zinman, Bernard, Hansen, Charlotte T., Hansen, Melissa V., Mark, Thomas, Moses, Alan C., Buse, John B.

Source: Diabetes, obesity & metabolism. 21(7):1625-1633

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100083016286.0x000001&indx=1&recIds=ETOCvdc_100083016286.0x000001

Effects of hypoglycaemia on working memory and regional cerebral blood flow in type 1 diabetes: a randomised, crossover trial

Authors: Gejl, Michael, Gjedde, Albert, Brock, Birgitte, Møller, Arne, van Duinkerken, Eelco, Haahr, Hanne L., Hansen, Charlotte T., Chu, Pei-Ling, Stender-Petersen, Kirstine L., Rungby, Jørgen

Source: Diabetologia. 61(3):551-561

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100125286529.0x000001&indx=1&recIds=ETOCvdc_100125286529.0x000001

Amyloidose er en sygdom med mange ansigter

Authors: Spanggaard, Magne B. L., Hansen, Charlotte T., Maiborg, Michael

Source: Ugeskrift for læger. 185(8):770-770

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN631864397&indx=1&recIds=ETOCRN631864397

Reasons for screening failure in the evoke and evoke+ trials of semaglutide for early AD.

Authors: Sano, Mary, Cummings, Jeffrey L., Feldman, Howard H., Hansson, Oskar, van der Flier, Wiesje M., Bardtrum, Lars, Jeppesen, Rose, Johannsen, Peter, Léon, Teresa, Hansen, Charlotte T., Scheltens, Philip

Source: Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Dec2024 Supplement 6, Vol. 20 Issue S6, p1-2, 2p

Evaluation of the serum free light chain (sFLC) analysis in prediction of response in symptomatic multiple myeloma patients: rapid profound reduction in involved FLC predicts achievement of VGPR.

Authors: Hansen, Charlotte T.¹, Pedersen, Per T.², Nielsen, Lars C.³, Abildgaard, Niels¹

Source: European Journal of Haematology. Nov2014, Vol. 93 Issue 5, p407-413. 7p.

Subject Terms: *MULTIPLE myeloma treatment, *TREATMENT effectiveness, *PROGRESSION-free survival, *IMMUNOGLOBULINS, *SCIENTIFIC observation, *BLOOD serum analysis

Clinical and preclinical validation of the serum free light chain assay: identification of the critical difference for optimized clinical use.

Authors: Hansen, Charlotte T.¹, Münster, Anna-Marie², Nielsen, Lars², Pedersen, Per³, Abildgaard, Niels¹

Source: European Journal of Haematology. Dec2012, Vol. 89 Issue 6, p458-468. 11p. 4 Charts, 5 Graphs.

Subject Terms: *PLASMA cell diseases, *MULTIPLE myeloma treatment, *IMMUNOASSAY, *ELECTROPHORESIS, *GAUSSIAN distribution

This result is not displayed to guests.
Login for full access.

Effect of laxatives on gastrointestinal functional recovery in fast-track hysterectomy: a double-blind, placebo-controlled randomized study

Authors: Hansen, Charlotte T., Sørensen, Mette, Møller, Charlotte, Ottesen, Bent, Kehlet, Henrik

Source: In American Journal of Obstetrics and Gynecology 2007 196(4):311-311

This result is not displayed to guests.
Login for full access.

Within-day Variability Based on 9-point Profiles Associates with Overall and Nocturnal Hypoglycemia Risk in Adults with Type 1 (T1D) or Type 2 Diabetes (T2D)

Authors: Bailey, Timothy, Bhargava, Anuj, Devries, J. Hans, Gerety, Gregg, Gumprecht, Janusz, Lane, Wendy, Wysham, Carol, Bak, Britta A., Hansen, Charlotte T., Chandarana, Keval, Philis-Tsimikas, Athena

Source: Canadian journal of diabetes. 41(5):S7-S7

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100066194072.0x000001&indx=1&recIds=ETOCvdc_100066194072.0x000001

Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type 2 Diabetes Requiring High-Dose Insulin

Authors: Warren, Mark L., Chaykin, Louis B., Jabbour, Serge, Sheikh-Ali, Mae, Hansen, Charlotte T., Nielsen, Thor S. S., Norwood, Paul

Source: Clinical diabetes. 35(2):90-90

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN615045017&indx=1&recIds=ETOCRN615045017

This result is not displayed to guests.
Login for full access.

16 - Within-day Variability Based on 9-point Profiles Associates with Overall and Nocturnal Hypoglycemia Risk in Adults with Type 1 (T1D) or Type 2 Diabetes (T2D)

Authors: Bailey, Timothy, Bhargava, Anuj, Devries, J. Hans, Gerety, Gregg, Gumprecht, Janusz, Lane, Wendy, Wysham, Carol, Bak, Britta A., Hansen, Charlotte T., Chandarana, Keval ^*, Philis-Tsimikas, Athena

Source: In Canadian Journal of Diabetes October 2017 41(5) Supplement:S7-S7

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.